Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo. (Q45859614)
Jump to navigation
Jump to search
scientific article published in July 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo. |
scientific article published in July 1999 |
Statements
Interleukin-4 adenoviral gene therapy reduces production of inflammatory cytokines and prostaglandin E2 by rheumatoid arthritis synovium ex vivo (English)
Woods JM
Tokuhira M
Berry JC
Katschke KJ Jr
Kurata H
Damergis JA Jr
Arai K